Avastin Slows Growth of Colon Cancer

According to Medscape, research presented at the 2007 Gastrointestinal Cancer Symposium in Orlando, Florida, determined that when Avastin (bevacizumab) was added to the chemotherapy regimen of people with metastatic colon cancer, their tumors took longer to progress.

Specifically, those receiving standard chemotherapy remained progression-free for an average of eight months. Those who received Avastin in addition to standard chemo remained progression-free for an average of nine-and-a-half months.

• FOLFOX4 Plus Avastin: Worth a Try?
  
• Is FOLFOX4 for You?
  
• FOLFOX4 Drug Combo Proven Effective

_{Source: Laino, Charlene. Avastin Slows Cancer Growth. Medscape. 22 Jan. 2007. Accessed 25 Jan. 2007. [http://www.medscape.com/viewarticle/551147?sssdmh=dm1.241670&src=nlpatient].}